Has Vineet Dua, MD received payments from drug or device companies?

Yes. Drug and device makers reported $77,150 in general payments to Vineet Dua, MD across 444 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vineet Dua, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vineet Dua, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vineet Dua, MD

Cardiovascular Disease · Dalton, GANPI 1447291216

Payments from drug & device makers

$77,150in general payments, 2019–2025

Across 444 payments — averaging $173.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amarin Pharma, Inc.$50K
Boston Scientific$13K
Novartis$10K
E.r. Squibb & Sons, L.L.C.$589
Heartflow, Inc.$486
Pfizer$469
plus $4K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amarin Pharma, Inc.	75	$49,603
Boston Scientific	37	$12,539
Novartis	72	$9,597
E.r. Squibb & Sons, L.L.C.	41	$589
Heartflow, Inc.	6	$486
Pfizer	23	$469
Merck	25	$438
Amgen	31	$429
AstraZeneca	19	$327
Johnson & Johnson	20	$305
Novo Nordisk	14	$268
Abbott	5	$261
Boehringer Ingelheim	11	$179
Kestra Medical Technology Services, Inc.	7	$146
Medtronic(2 entities)	4	$142
Esperion Therapeutics, Inc.	8	$132
Cvrx, Inc.	3	$129
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	5	$119
Inspire Medical Systems, Inc.	1	$117
W. L. Gore & Associates, Inc.	5	$105
Edwards Lifesciences	1	$100
Bayer	5	$98
Cleerly, Inc.	1	$66
Lexicon Pharmaceuticals, Inc.	4	$64
Daiichi Sankyo Inc.	2	$53
Alnylam Pharmaceuticals Inc.	2	$53
Bridgebio Pharma, Inc.	2	$42
Abiomed	1	$33
Imperative Care, Inc	1	$33
Scpharmaceuticals Inc.	2	$32
Sanofi-aventis U.S. LLC	2	$32
United Therapeutics Corporation	1	$30
Atricure, Inc.	1	$26
Kiniksa Pharmaceuticals International, PLC	1	$23
Siemens Medical Solutions USA, Inc.	1	$19
Impulse Dynamics (USA) Inc.	1	$17
Kiniksa Pharmaceuticals, Ltd.	1	$17
Actelion Pharmaceuticals US, Inc.	1	$15
Arbor Pharmaceuticals, Inc.	1	$12
Vivaquant Inc, Dba Rhythm Express	1	$7

How this compares

$77,150 in reported general payments places this provider in the 90th percentile of 640 cardiovascular disease providers in Georgia.

See all cardiovascular disease providers in Georgia →

Medicare billing

Part B allowed, 2024

$349,119

Medicare patients

2,294

Services billed

6,714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Dalton

Narendra SinghJohns Creek$5.4M
Elizabeth OfiliAtlanta$4.5M
Sanjay YadavAtlanta$3.7M
Arshed QuyyumiAtlanta$3.4M
Naresh ParikhNorcross$2.8M
Nicolas ChronosEatonton$2.4M
Bobby KhanAtlanta$1.7M
Hunter ChampionColumbus$1.5M
David SuhTucker$1.1M
Michael MorrisAtlanta$1.1M

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →